Real-lifeeffectiveness oferlotinib assecond-line treatmentof stage IIIB/IVsquamous non-smallcell lung cancer:Results of the PEPiTAobservational study I. MonnetClarisse Audigier-ValetteNicolas Girard2016 год

Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational study
статья из журнала